Intraepidermal Injections of Autologous Epidermal Cell Suspension: A New Promising Approach to Dermatological Disorders. Preliminary Study
December 2017
Studysummary This study describes a preliminary examination showing that an intraepidermal injection of autologous epidermal cell suspension contains a significant number of viable cells after 7 days of culture, suggesting potential use in treating skin disorders like alopecia and as an anti-aging therapy. Our plain-language summary of this paper — not a Tressless recommendation.
The 2017 study "Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study" investigated the potential of autologous epidermal cell suspension as a treatment for skin disorders, including non-scarring and scarring alopecia. The process involved injecting a patient's own epidermal cells, cultured for 7 days, back into their skin. The study, which involved 10 healthy volunteers, found a significant number of these cells remained viable after 7 days in culture. The procedure was deemed simple, fast, safe, and relatively inexpensive, with limited side effects. However, the researchers acknowledged the need for further studies to validate their findings in a larger group and through controlled and randomized clinical trials.
